SYSTEM AND METHOD FOR REMOTE COLLECTION AND ANALYSIS OF VOLATILE ORGANIC COMPONENTS IN BREATH

• US 20130253358A1
• Filed: 03/06/2013
• Published: 09/26/2013
• Est. Priority Date: 03/07/2012
• Status: Abandoned Application

• Current Assignee: Menssana Research Incorporated
• Original Assignee: Menssana Research Incorporated
• Inventors: PHILLIPS, MICHAEL
• Application Number:
  US13/786,921
• Publication Number:
  US 20130253358A1
• Time in Patent Office: Days
• US Class Current: 600/532
• CPC Class Codes: A61B 5/0022 Monitoring a patient using a global network, e.g. telephone networks, internet
• CPC Class Codes: A61B 5/082 Evaluation by breath analysis, e.g. determination of the chemical composition of exhaled breath A61B5/083, A61B5/091 take precedence
• CPC Class Codes: A61B 5/097 Devices for facilitating collection of breath or for directing breath into or through measuring devices
• CPC Class Codes: G01N 33/497 of gaseous biological material, e.g. breath

Abstract

A tool for telemedicine including an improved breath collection system of human breath to facilitate the analysis of volatile organic components (VOCs) contained in human breath in which breath tests can be performed at remote sites for rapid detection of different diseases. The system can include a standoff breath collection device including an arcuate structure for concentration and analysis of volatile organic components (VOCs) at the point-of-use that avoids the use of mouthpieces found in conventional breath collection apparatuses.

Claims

1. A telemedicine system for collection and analysis of volatile organic components in alveolar breath comprising:

a point-of-care system, said point-of-care system includes a breath collector to collect a sample of the alveolar breath, means for analysis of said collected breath to generate breath data of the volatile organic components contained in the alveolar breath and means for communicating with a central site to forward the breath data to said central site, and

said central site including means for receiving said breath data and means for interpreting said breath data to identify if a pattern of the volatile organic components is consistent with a particular disease,

wherein said central site forwards the interpreted data to said point-of-care system.

2. The telemedicine system of claim 1 wherein said point-of-care system further comprises a concentrator for concentrating the volatile organic components of the alveolar breath and a desorber for desorbing the volatile organic components, wherein the desorbed volatile organic components are analyzed in said means for analysis of said collected breath.

3. The telemedicine system of claim 1 wherein the means for analysis of said collected breath includes a surface acoustic wave detector (GC SAW).

4. The telemedicine system of claim 1 wherein the means for interpreting said breath data includes algorithm learning to refine diagnostic algorithms used in means for interpreting said breath data.

5. The telemedicine system of claim 1 wherein said central site includes a generate report module to generate report of the interpretation of data from the means for interpreting said breath data, said report being transmitted from said central site to said point-of-care system.

6. The telemedicine system of claim 1 wherein said central site includes means for remote control of the point-of-care system to provide instrument monitoring quality assurance to ensure the point-of-care system is performing according to predetermined parameters.

7. The telemedicine system of claim 6 wherein the means for remote control of the point-of-care system calibrates instruments or apparatus used in the point-of-care system to quantify the abundance of the volatile organic components (VOCs) in the breath sample.

8. The telemedicine system of claim 6 wherein the means for remote control of the point-of-care system determines analytical parameters used in the means for analysis of said collected breath analysis to optimize detection of specific diseases.

9. The telemedicine system of claim 1 wherein said central site includes means for

customer management to determine customer management from the breath data and the interpreted data.

10. The telemedicine system of claim 1 wherein the means for

customer management provides billing services.

11. The telemedicine system of claim 1 wherein the breath collector comprises a dome system, said dome system including a collection dome.

12. The telemedicine system of claim 11 wherein said collection dome is a clear acrylic hemisphere.

13. The telemedicine system of claim 11 wherein said collection dome is coupled to a concentrator for concentrating the volatile organic components of the alveolar breath with tubing.

14. The telemedicine system of claim 11 wherein said dome system further comprises

a fan positioned below said collection dome for flushing said collection dome.

15. A method for remote collection and analysis of volatile organic components in alveolar breath comprising the steps of:

collecting a sample of the alveolar breath at a point-of-care;

generating breath data of the volatile organic components contained in the alveolar breath;

communicating with a central site to forward the breath data to said central site; and

interpreting said breath data at said central site for identifying if a pattern of the volatile organic components is consistent with a particular disease at the central site to determine interpreted data; and

forwarding the interpreted data to said point-of-care.

16. The method of claim 15 wherein said step of

interpreting said breath data includes algorithm learning to refine diagnostic algorithms used for interpreting said breath data.

17. The method of claim 15 further comprising the steps of generating a report of the interpretation of said breath data and transmitting said report from said central site to said point-of-care.

18. The method of claim 15 further comprising the step of controlling of the point-of-care at said central site to provide instrument monitoring quality assurance to ensure the point-of-care is performing according to predetermined parameters.

19. The method of claim 15 further comprising the step of controlling of the point-of-care at said central site to calibrate instruments or apparatus used in the point-of-care to quantify the abundance of the volatile organic components (VOCs) in the breath sample.

20. The method of claim 15 further comprising the step of controlling of the point-of-care at said central site to determine analytical parameters used in the collecting step to optimize detection of specific diseases.

21. The method of claim 15 further comprising the step of providing billing services to the point-of-care from the central site, the billing services being based on the breath data and the interpreted data.

22. The method of claim 15 wherein the collecting step comprises collecting the breath with a dome system, said dome system including a collection dome.